Innospec Inc. $IOSP Shares Bought by GSA Capital Partners LLP

GSA Capital Partners LLP grew its holdings in Innospec Inc. (NASDAQ:IOSP) by 46.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,274 shares of the specialty chemicals company’s stock after acquiring an additional 8,974 shares during the period. GSA Capital Partners LLP owned about 0.11% of Innospec worth $2,182,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of Innospec in the second quarter worth $28,000. EverSource Wealth Advisors LLC boosted its position in Innospec by 1,159.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 487 shares during the period. Versant Capital Management Inc grew its position in shares of Innospec by 378.1% during the third quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company’s stock worth $42,000 after acquiring an additional 431 shares during the last quarter. State of Wyoming increased its stake in shares of Innospec by 27.5% in the second quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after purchasing an additional 173 shares during the period. Finally, Smartleaf Asset Management LLC raised its stake in Innospec by 75.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,317 shares of the specialty chemicals company’s stock valued at $101,000 after acquiring an additional 566 shares in the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.

Innospec Stock Down 0.3%

Innospec stock opened at $86.58 on Tuesday. Innospec Inc. has a 12-month low of $70.10 and a 12-month high of $112.74. The business’s 50-day simple moving average is $80.66 and its 200 day simple moving average is $79.17. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of -2,886.00 and a beta of 0.91.

Analyst Ratings Changes

Several equities analysts have recently issued reports on IOSP shares. Wall Street Zen raised shares of Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Innospec in a research note on Monday, December 22nd. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce”.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.